Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Halstead

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications|November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationKatie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
The Journal of Infectious Diseases|February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications|November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationKatie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
The Journal of Infectious Diseases|February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
Pageof 4